Search results
Results from the WOW.Com Content Network
Infection rates dropped and stabilised throughout 2022 and 2023, leading to the end of COVID-19's classification as a severe transmissible disease in June 2023. [22] Although the pandemic has heavily disrupted the country's economy, [23] Vietnam's GDP growth rate has remained one of the highest in Asia-Pacific, at 2.91% in 2020. Due to the more ...
Vietnam will receive the feedback of the plan from NDVP review committee as one of the required steps to receive COVID-19 vaccines through COVAX Facility – a global mechanism for developing, manufacturing, supplying and procuring COVID-19 vaccines for all country, especially for low and middle-income economies. [30]
The phase III study is the adaptive, multicenter, randomized, double-blind, placebo control study to evaluate the safety, immunogenicity, and efficacy of the Nanocovax vaccine against COVID-19 in volunteer subjects 18 years of age and older. [17]
2020-01-23: 2 (n.a.): 0 (n.a.): ⋮: 2 (=): 0 (n.a.): 2020-01-28: 2 (=): 0 (n.a.): ⋮: 2 (=): 0 (n.a.): 2020-01-31: 5 (+3): 0 (n.a.): 2020-02-01: 6 (+1): 0 (n.a ...
In the European Union, the combination is indicated for the treatment of COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms (88 lb) who do not require supplemental oxygen and who are at high increased risk of progressing to severe COVID‑19; [10] and for the prevention of COVID‑19 in people aged twelve years of age and older weighing at least 40 kilograms ...
The COVID-19 pandemic (also known as the coronavirus pandemic and COVID pandemic), caused by severe acute respiratory syndrome coronavirus 2 , began with an outbreak of COVID-19 in Wuhan, China, in December 2019. It spread to other areas of Asia, and then worldwide in early 2020.
Pages in category "Vietnamese COVID-19 vaccines" The following 4 pages are in this category, out of 4 total. This list may not reflect recent changes. A. ARCT-154; N.
In May 2020, Vietnam declared that their COVID-19 vaccine was developed after scientists successfully generated the novel coronavirus antigen in the lab. The vaccine has been developed by collaborating scientists at VABIOTECH in Hanoi and the Bristol University , it will be tested further in animals and evaluated for safety and effectiveness ...